Blood Glucose Concentration Measurement Device (BGM)

From GM-RKB
(Redirected from glucometer)
Jump to navigation Jump to search

A Blood Glucose Concentration Measurement Device (BGM) is a medical device for determining approximate blood glucose concentration (a biomarker).



References

2021

2015

  • (Lan et al., 2015) ⇒ Tian Lan, Yu Xiang, and Yi Lu. (2015). “Detection of Protein Biomarker Using a Blood Glucose Meter.” In: Mobile Health Technologies, pp. 99-109 . Humana Press, New York, NY,
    • QUOTE: ... To lower the costs and shorten the cycles of developing new mHealth technologies that can be generally applied to a wide range of biomarkers, we proposed and demonstrated an alternative approach of repurposing existing technologies and devices for a much wider range of applications. The blood glucose meter (BGM) is an excellent platform to leverage, because it has gone through decades of research and development, making the current generation of BGMs accurate, well designed for simple operation, low cost, and portable. More importantly, several network-connected smartphone-compatible BGMs [3–5] are available and some of them have already been approved by FDA. In fact, these network-connected BGMs account for the majority of current mHealth devices capable of monitoring biomarkers [1]. Furthermore, BGM technologies are constantly being improved due to the growing number of diabetes [6]. By taking advantage of this highly developed and widely available mHealth device, we and others have developed novel methodologies to transform the binding of non-glucose biomarkers by either aptamers or antibodies into glucose so that network-connected smartphone-compatible BGMs can be used to detect and monitor a wide range of targets, such as metal ions, small organic molecules, protein markers, and nucleic acids